Industry news
SEMBIOSYS ISSUED KEY U.S. PATENT FOR THE PRODUCTION OF APOLIPOPROTEINS IN PLANTS
In order to access this content you must be logged in and have a subscription to Pharmalicensing Intelligence.
Pharmalicensing Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Subscribe now for instant access to the benefits Pharmalicensing Intelligence has to offer. Find out more.
Company details
If you want to find out more about the company visit SemBioSys Genetics profile.
Related reports
Market Research Reports provided by reports.iptechex.com
Mar 2011 - 67 pages - $250
May 2011 - 25 pages - $250
Nov 2010 - 29 pages - $600
Apr 2007 - 19 pages - $1,400
Mar 2011 - 24 pages - $500
Oct 2011 - 40 pages - $1,500
Mar 2011 - 17 pages - $250
Jul 2011 - 17 pages - $1,000
Apr 2011 - 5 pages - $500
Jul 2011 - 16 pages - $1,000
Related news
Latest News
- SEMBIOSYS ISSUED KEY U.S. PATENT FOR THE PRODUCTION OF APOLIPOPROTEINS IN PLANTS
- StemCells, Inc's Technology Used to Create First Genetically Engineered Rat Derived from Rat Embryonic Stem Cells
- Marina Biotech Announces Allowance of Fundamental RNAi Delivery Patent From U.S. Patent Office
- Sequella and University of Maryland Restate Exclusive License for Jointly-owned Event Marker System Technology
- Ranier Technology announces the European Patent Grant on its Precision Polyurethane Manufacturing (PPM) Technology
- More news... | RSS Feed...
Most Viewed
SEMBIOSYS ISSUED KEY U.S. PATENT FOR THE PRODUCTION OF APOLIPOPROTEINS IN PLANTS
Marina Biotech Announces Allowance of Fundamental RNAi Delivery Patent From U.S. Patent Office
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us